The North America Cannabis Testing Market is experiencing significant growth due to regulatory advancements and rising demand for cannabis-based products. In 2025, the market size was valued at USD 2,470 million and is projected to reach USD 6,430 million by 2035, expanding at a CAGR of 9.3% from 2024 to 2035.
The economic impact of tariffs on "North America Cannabis Testing Market".
Market Growth Drivers
Stringent state and federal regulations continue to drive the adoption of comprehensive cannabis testing. For instance, Steep Hill Labs reported a substantial increase in testing volumes due to revised safety standards in Canada and various U.S. states, including mandatory checks for potency, residual solvents, and microbial contaminants. These regulations are pushing producers to partner with certified laboratories, boosting the overall market.
Rising consumer awareness regarding product safety and quality has led to increased demand for tested cannabis products. Companies like SC Labs have noted a greater influx of clients wanting to validate claims regarding THC and CBD content, ensuring the absence of harmful pesticides. This consumer-led push is encouraging even smaller growers and product manufacturers to prioritize third-party testing.
Market Trends
Advancements in testing technology, such as the adoption of liquid chromatography-mass spectrometry (LC-MS), are enabling more accurate and rapid analysis of cannabinoids and contaminants. Labs like CannaSafe are investing in automated systems to expedite turnaround times and improve data reliability, thus setting new industry standards.
The integration of digital tracking and blockchain solutions in testing processes is on the rise. Green Scientific Labs recently deployed a blockchain-based system to improve transparency and traceability in product testing, assuring consumers and regulators about the integrity of test results from seed to sale.
Market Opportunity
Expansion into edibles and infused product testing presents a lucrative growth segment as consumer preferences diversify. For example, Kaycha Labs has entered partnerships with edible product manufacturers to provide tailored analytical solutions, ensuring compliance and safety for a broader range of cannabis-based consumables.
The opening of new state markets following legislative developments offers a significant opportunity. Eurofins Scientific has announced plans to establish additional testing facilities in states like New York and New Jersey, capitalizing on the growth expected from emerging adult-use cannabis markets.
North America Cannabis Testing Market Revenue (USD Million), 2020-2035
The chart illustrates the steady revenue growth of the North America Cannabis Testing Market from 2020 to 2035. Starting at USD 980 million in 2020, the market surges to USD 1,158 million in 2021 and continues its upward trajectory, reaching USD 2,470 million in 2025. The projected CAGR of 9.3% is reflected in the curve, with revenues crossing USD 6,430 million by 2035. The consistent market expansion is driven by regulatory support, technology upgrades, and rising consumer demand for quality assurance, indicating a robust and sustained market outlook.
North America Cannabis Testing Market Share by Region (%), 2025
In 2025, the United States dominates the North America Cannabis Testing Market, accounting for approximately 76% of total market share due to favorable regulations, a large cannabis industry, and significant investment in testing facilities. Canada follows with a 17% share, driven by broad legalization and a mature regulatory framework. Mexico's emerging market holds a 4% share, while the rest of North America, including smaller markets, collectively make up 3%. The pie chart reflects the strong leadership of the U.S. market, with Canada as a substantial contributor and other regions showing high growth potential.
Recent Developments in North America Cannabis Testing Market (Last 6 Months)
In April 2024, Steep Hill Labs announced the launch of a new rapid screening platform leveraging AI-powered analytics. This platform significantly accelerates the detection of pesticides and microbial contaminants, enabling quicker market access for cannabis producers and ensuring compliance with evolving regulations.
In March 2024, Green Scientific Labs unveiled a partnership with Chainlink to integrate blockchain for real-time verification of lab test results. This technology ensures greater transparency, reduces tampering risk, and enhances consumer trust across key U.S. and Canadian markets.
In January 2024, Kaycha Labs expanded operations in New Jersey and New York by opening two state-of-the-art facilities. These labs focus on advanced contaminant testing, including heavy metal screening in edibles, positioning the company to serve new adult-use markets created by recent legal changes.
Press Releases